Docturnal is an online platform that enables individuals to find information and diagnostic services related to diabetes, cancer, and more.
Docturnal offers custom content for diabetes, heart, cancer, Autism, and Arthritis for users who have a condition or their concerned ones. The company is a point of care screening and diagnostics provider of non-invasive and proactive detection of diseases. Docturnal’s product portfolio also includes solutions for CoPD and Asthma with a pipeline of lung based ailments that can be identified by an aural component. Docturnal products are designed to make detection of diseases easy and hassle-free. Essentially it means being accessible and affordable to the last mile.Docturnal was established in April 2016.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 3, 2017 | Seed | — | 1 | AIRmaker | — | Detail |